Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-29

Clinical Trial Update: CD16+ Monocytes in Coronary Heart Disease (CHD)

View source ↗

Summary

The clinical trial evaluating CD16+ monocytes in coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Coronary Heart Disease | Status: COMPLETED